That's a good point I hadn't seen brought up. I have also heard that a big fear with the current rampant spread is that it also provides ample opportunity for evolution, especially with the strains that are better at spreading. Maybe a damned if you do, damned if you don't in both of those cases.
This sucks I feel for you. Out here we are past capacity. By in state did you mean inside?
www.statnews.com
www.statnews.com
I think ND was helped by 12% of their entire population already having it. And that's going by reported cases.
LA county: 1 death every 8 minutes
Looks like they are rapidly approaching 10% (reported) infected, which is horrible. Especially considering their population is 13x that of North Dakota.
I've been reading some about this new B-117 variant of Covid and they are saying that it more easily spreads among children as well. They aren't sure if kids had a protective effect against other variants that we are not seeing here, or that the new variant can spread even with the current social distancing and mask wearing. The last thing I want to do is be an alarmist about any of this but I do suggest that you put this one on your radar as it could really impact people in LA since the virus is already uncontrolled as is.
www.prospectmagazine.co.uk
medshadow.org
www.sciencenews.org
During testing, there was a higher chance of the usual side-effects after the 2nd dose compared to the first (things like headaches, body aches and chills). They were brief and controllable with over-the-counter medication (acetaminophen, ibuprophen). Otherwise, there are very little side-effects being reported beyond allergies and a few cases of Bell's (unclear if it's vaccine-related though, as the observed proportion was lower than the incidence in a normal population). I haven't read about anything else significant.
COVID-19 Vaccine Side Effect Tracker - MedShadow Foundation | Independent Health & Wellness Journalism
We created the MedShadow Vaccine Tracker. Look at the only tracker focused on side effects and adverse events of COVID-19 Vaccines.
Thank you both. This relaxes my mind. I won't bother to take any of the info to social media though, people there don't like science. Hmmm, maybe if I yelled this info while driving and posted it to Youtube it would resonate.Common side effects for the vaccine treatment were mild-to-moderate injection-site pain, headache, and fatigue. Overall, severe adverse events occurred in 0.5% of the intervention group and 0.2% of the placebo group, and none were classified as immediately life-threatening or as a cause of death.
Similar to Moderna's vaccine, the most common adverse effects were mild-to-moderate injection-site pain, fatigue, and headaches, as reported by a subgroup of 8,183 people. Those younger than 55 experienced more injection-site pain and systemic symptoms than older patients.
"The frequency of any severe systemic event after the first dose was 0.9% or less. Severe systemic events were reported in less than 2% of vaccine recipients after either dose, except for fatigue (in 3.8%) and headache (in 2.0%) after the second dose," the researchers write. No vaccine-related deaths occurred in any study participant.
Peer-reviewed data show high protection for leading COVID vaccines
www.cidrap.umn.edu
Here's a Q&A that talks about side effects, but there is no data behind this one that I can see:
Johns Hopkins Bloomberg School of Public Health
Protecting Health, Saving Lives—Millions at a Time.www.jhsph.edu
Moderna’s vaccine initially showed an impressive 100 percent efficacy at preventing severe symptoms in people who received it. While 30 people in the clinical trial’s placebo group developed severe disease, no vaccinated person did. Since that analysis occurred, however, one person in the vaccine group may have developed a severe case, but that is not yet validated, Rachel Zhang, a medical officer with the FDA, said in the Dec. 17 hearing.
Pfizer originally announced in a Nov. 18 news release that its vaccine appeared to prevent people from becoming severely ill as well. But there have been too few cases in that trial to know for sure, experts say (SN: 11/18/20; 12/10/20). Four Pfizer trial participants developed severe COVID-19, three of whom received the placebo.
Still, “it’s very clear for both the Moderna and Pfizer vaccines that symptomatic coronavirus [cases] and coronavirus infections requiring hospitalization are dramatically reduced,” says Andrea Cox, a viral immunologist at Johns Hopkins University.
How the FDA-authorized Moderna COVID-19 vaccine compares to Pfizer’s | Science News
The FDA has granted emergency use authorization to Moderna’s COVID-19 vaccine, bringing the number of vaccines available in the United States to two.
Here are some scholarly articles I found. It looks like the symptoms are very similar to the flu vaccine. We really won't have great, peer review articles with accurate data and methods for another few months. I think that once we have a few months of lag time, we should get a lot better data on symptom rates and severity.
